(BUFFALO, NY) More than 30 Roswell Park Cancer Institute faculty, staff, patient family members and supporters today took part in the Goin’ Bald for Bucks Team Roswell event, shaving their heads or cutting ten inches of their hair to raise funds and show
BUFFALO, NY — Preclinical research by a team from Roswell Park Cancer Institute (RPCI) has demonstrated for the first time the way in which a class I histone deacetylase (HDAC) inhibitor, entinostat, appears to boost the effectiveness of cancer immunother
BUFFALO, NY — Roswell Park Cancer Institute (RPCI) has once again been included on Becker’s Hospital Review’s annual list of centers that serve as leaders in cancer research, prevention, treatment and education.
BUFFALO, NY — Smokers strongly favor decreasing the addictiveness of cigarettes, according to results from an International Tobacco Control (ITC) United States Supplemental Survey published in a recent issue of the journal BMC Public Health.
BUFFALO, NY — Several Roswell Park Cancer Institute (RPCI) faculty members have been selected to receive prestigious honors from their colleagues in recognition of their professional achievements, or have been elected to leadership positions in profession
On Monday, January 30, 2012, more than two dozen doctors, researchers, members of the Board of Directors and leaders from Roswell Park Cancer Institute (RPCI) will travel to Albany, NY, to meet with state leaders.
PLEASE NOTE:As expected, Roswell Park Cancer Institute continues to receive a very high volume of calls and emails from patients and their families regarding the vaccine clinical research study that was announced at our press conference, January 24.